Trial Profile
Single-Arm, Open-label, Multicenter, Phase 2 Clinical Trial to Assess the Efficacy and Safety of Single-Agent Camtobell Inj.(Belotecan) Administered on A Weekly Schedule in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients Previously Treated With Chemotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2012
Price :
$35
*
At a glance
- Drugs Belotecan (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 21 Dec 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 21 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2009 New trial record